Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
Regeneron Pharmaceuticals, a leading biopharmaceutical company, is gaining recognition for its innovative approach and strong financial performance. With a diverse ...